Clinical and Imaging Features of Non-Small Cell Lung Cancer with G12C KRAS Mutation

SIMPLE SUMMARY: KRAS G12C mutations are important oncogenic mutations in lung cancer that can now be targeted by allosteric small molecule inhibitors. We assessed the imaging features and patterns of metastases in these lung cancers compared to other mutated lung cancers. We found that KRAS G12C NSC...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Markus Y., Zhang, Eric W., Strickland, Matthew R., Mendoza, Dexter P., Lipkin, Lev, Lennerz, Jochen K., Gainor, Justin F., Heist, Rebecca S., Digumarthy, Subba R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304953/
https://www.ncbi.nlm.nih.gov/pubmed/34298783
http://dx.doi.org/10.3390/cancers13143572

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304953/
https://www.ncbi.nlm.nih.gov/pubmed/34298783
http://dx.doi.org/10.3390/cancers13143572

Ejemplares similares